Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 762Lung Neoplasms 339Ovarian Neoplasms 318Breast Neoplasms 277Fallopian Tube Neoplasms 158Triple Negative Breast Neoplasms 143Small Cell Lung Carcinoma 140Neoplasms 134Squamous Cell Carcinoma of Head and Neck 122Carcinoma, Ovarian Epithelial 114Neoplasm Metastasis 84Head and Neck Neoplasms 80Endometrial Neoplasms 76Uterine Cervical Neoplasms 70Esophageal Neoplasms 70Adenocarcinoma of Lung 68Neuroblastoma 55Central Nervous System Neoplasms 52Lymphoma, Large B-Cell, Diffuse 49Carcinoma 49Brain Neoplasms 48Recurrence 47Prostatic Neoplasms 44Parkinson Disease 4, Autosomal Dominant Lewy Body 44Urinary Bladder Neoplasms 42Esophageal Squamous Cell Carcinoma 41Lymphoma 39Melanoma 35Carcinoma, Squamous Cell 33Lymphoma, Non-Hodgkin 31

Interventions

Hyperthermic Intraperitoneal Chemotherapy 1Docetaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Ovarian Epithelial Cancer Recurrent × Carboplatin × Clear all
NCT02026921 2014-01-03

A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian Cancer

Nordic Society of Gynaecological Oncology - Clinical Trials Unit

Phase 2 Completed
74 enrolled
Gynecologic

Ovarian Epithelial Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon âš¡